<?xml version="1.0" encoding="UTF-8"?>
<crossref_result xmlns="http://www.crossref.org/qrschema/3.0" version="3.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.crossref.org/qrschema/3.0 http://www.crossref.org/schemas/crossref_query_output3.0.xsd">
  <query_result>
    <head>
      <doi_batch_id>none</doi_batch_id>
    </head>
    <body>
      <query status="resolved">
        <doi type="journal_article">10.31254/phyto.2024.13212</doi>
        <crm-item name="publisher-name" type="string">BioMed Research Publishers</crm-item>
        <crm-item name="prefix-name" type="string">BioMed Research Publishers</crm-item>
        <crm-item name="member-id" type="number">16195</crm-item>
        <crm-item name="citation-id" type="number">160629334</crm-item>
        <crm-item name="journal-id" type="number">316921</crm-item>
        <crm-item name="deposit-timestamp" type="number">20240512122131292</crm-item>
        <crm-item name="owner-prefix" type="string">10.31254</crm-item>
        <crm-item name="last-update" type="date">2024-05-12T16:21:46Z</crm-item>
        <crm-item name="created" type="date">2024-05-12T16:21:38Z</crm-item>
        <crm-item name="citedby-count" type="number">0</crm-item>
        <doi_record>
          <crossref xmlns="http://www.crossref.org/xschema/1.1" xsi:schemaLocation="http://www.crossref.org/xschema/1.1 http://doi.crossref.org/schemas/unixref1.1.xsd">
            <journal>
              <journal_metadata>
                <full_title>The Journal of Phytopharmacology</full_title>
                <abbrev_title>J Phytopharmacol</abbrev_title>
                <issn media_type="electronic">2320480X</issn>
                <doi_data>
                  <doi>10.31254/phyto</doi>
                  <resource>https://www.phytopharmajournal.com/</resource>
                </doi_data>
              </journal_metadata>
              <journal_issue>
                <publication_date media_type="online">
                  <month>4</month>
                  <day>30</day>
                  <year>2024</year>
                </publication_date>
                <journal_volume>
                  <volume>13</volume>
                </journal_volume>
                <issue>2</issue>
              </journal_issue>
              <journal_article publication_type="full_text">
                <titles>
                  <title>GCMS-based Phytochemical Profiling of L. camara Induces Apoptosis and Cell Cycle Arrest in Lung Cancer</title>
                </titles>
                <contributors>
                  <person_name sequence="first" contributor_role="author">
                    <given_name>C</given_name>
                    <surname>Ashajyothi</surname>
                    <ORCID>https://orcid.org/0000-0002-6927-681X</ORCID>
                  </person_name>
                  <person_name sequence="additional" contributor_role="author">
                    <given_name>Sandeep Y</given_name>
                    <surname>Sai</surname>
                  </person_name>
                  <person_name sequence="additional" contributor_role="author">
                    <given_name>R</given_name>
                    <surname>Pooja</surname>
                  </person_name>
                </contributors>
                <jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xml:lang="en">
                  <jats:p>In this paper, the focus is on the phytochemical study of Lantana camara L. leaf extract, specifically its antioxidant and anti-cancer effects. The study shows that all solvent extracts have significant antioxidant and anticancer activity. However, the methanol liquid extract of L. camara leaf contains higher levels of metabolites than other solvents. The methanolic extracts of the leaves of four distinct species of Lantana camara also have high levels of terpenoid chemicals, which demonstrate strong antioxidant and free radical elimination properties. With further research, it is possible that useful medications can be developed for the treatment of various human diseases, especially lung cancer.</jats:p>
                </jats:abstract>
                <publication_date media_type="online">
                  <month>4</month>
                  <day>30</day>
                  <year>2024</year>
                </publication_date>
                <pages>
                  <first_page>177</first_page>
                  <last_page>183</last_page>
                </pages>
                <crossmark>
                  <crossmark_version>1</crossmark_version>
                  <crossmark_policy>10.31254/biomed-crossmark-policy</crossmark_policy>
                  <crossmark_domains>
                    <crossmark_domain>
                      <domain>www.biomedresearch.org</domain>
                    </crossmark_domain>
                  </crossmark_domains>
                  <crossmark_domain_exclusive>false</crossmark_domain_exclusive>
                </crossmark>
                <doi_data>
                  <doi>10.31254/phyto.2024.13212</doi>
                  <resource>https://www.phytopharmajournal.com/assets/pdf_files/Vol13_Issue2_12.pdf</resource>
                </doi_data>
              </journal_article>
            </journal>
          </crossref>
        </doi_record>
      </query>
    </body>
  </query_result>
</crossref_result>